OraQuick HIV Self-Test, 1 Test

OraQuick Rapid HIV Testing, Anytime, Anywhere, Made Easy. OraQuick HIV Self-Test Description: The OraQuick HIV Self-Test is the first and only FDA-approved oral fluid rapid, over-the-counter test capable to detect antibodies to HIV-1 and HIV-2. It is the same trusted test used by healthcare providers in the comfort of your own space. The test provides results in 20 minutes and is easy to use. The test is approved for use in individuals 14 years of age and older. Time to result: 20 minute, easy to use test Connection to the OraSure Support Center for assistance and guidance Convenient: Pain free oral fluid-based test; no needles necessary Can be used anytime, anywhere Important Information: The OraQuick In-Home HIV Test has been re-branded to the OraQuick HIV Self-Test with a fresh new design that prioritizes environmental sustainability. Rest Assured, the OraQuick HIV Self-Test is just as reliable and easy to use as before. The changes are solely in the packaging and branding, not the functionality or accuracy of the test. The OraQuick In-Home HIV Test Kit will be available until supplies last. Made in USA The OraQuick ADVANCE™ Rapid HIV-1/2 Antibody Test detects antibodies to HIV-1 and HIV-2 in 20 minutes. Rapid Provides results in 20 minutes enabling patients to learn their status in a single visit and allows HIV positive patients to be connected to care immediately. Flexible Approved for oral fluid, plasma, fingerstick or venipuncture whole blood specimens. Ideal for both clinical and non-clinical settings. Accurate Greater than 99% agreement with confirmatory Western blot.1 Simple CLIA-waived for oral fluid, fingerstick and venipuncture whole blood and offers the ability to test in non-traditional testing environments, such as outreach programs and mobile testing clinics. Walk-away procedure allows providers to batch tests, enabling more people to get tested, reducing indirect costs and improving turnaround time. Reliable Offers patients accurate HIV testing without the need for blood or needles. Pain-free testing with oral fluid means more people get screened, more HIV positive patients are connected to care and fewer people are exposed. The current CDC guidelines urge routine HIV screening2 The Facts More than 1.2 million people in the U.S. are infected with HIV and the CDC estimates that one in seven don’t know it.3 individuals who are unaware of their infection account for ~40% of transmissions.4 Fewer than 40% of people in the U.S. have ever had an HIV test.5 Risk-based testing is NOT reaching the goal of identifying all HIV+ people. The CDC guidelines recommend taking these steps to help stop the spread of HIV Screen all people 13-64 years old in all healthcare settings. Identify all HIV+ people. Connect them to care early. Educate people about risk factors to empower them to stay healthy. OraQuick ADVANCE™ Rapid HIV-1/2 Antibody Test Package Insert. Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings, MMWR, September 22, 2006/Vol. 55/No. RR-14. https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics http://www.theaidsinstitute.org/sites/default/files/attachments/National%20HIV%20Testing%20Day%20press%20release.pdf https://www.hiv.gov/blog/most-americans-have-never-had-hiv-test-new-data-show Flexible Specimens for Clinical and Non-Clinical Settings Fingerstick Step 1 - Collect Specimen & Mix in buffer Step 2 - Insert device into buffer Step 3 - Read between 20 and 40 minutes Non-Reactive Line in the C Zone Reactive Line in the C & T Zones Venipuncture Whole Blood Step 1 - Collect Specimen & Mix in buffer Step 2 - Insert device into buffer Step 3 - Read between 20 and 40 minutes Non-Reactive Line in the C Zone Reactive Line in the C & T Zones